Hepatic resection of non-colorectal non-endocrine liver metastases

Gandy, Robert C.; Bergamin, P.; Haghighi, Koroush S.

doi:10.1016/j.hpb.2016.02.610

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These percentages are similar to the group of patients with colorectal cancer metastases to the liver. Liver resections due to metastases of gastric carcinomas, however, constitute only 5-9% of resections due to metastases other than colorectal cancer [4][5][6][7]. This is due, among other things, to the fact that until recently, patients with metastases of gastric cancer into the liver were disqualified from surgical treatment and offered chemotherapy only.…”

Section: Introductionmentioning

confidence: 99%

Metastases of gastric cancer into the liver – the authors’ own experience and literature review

Krawczyk¹,

Skalski²,

Grąt³

et al. 2019

Nowotwory. Journal of Oncology

View full text Add to dashboard Cite

Introduction . Synchronous metastases of gastric cancer to the liver occur in 3-14% of patients with this cancer, and metachronous lesions in 37% of patients after radical gastrectomy. Liver resections due to metastases of gastric carcinomas represent only 5-9% of resections due to metastases other than colorectal cancer. Until recently, patients with gastric carcinoma metastases to the liver were classified in the IV stage of cancer and the therapy was limited to chemotherapy or palliative treatment only. Material and methods . The paper presents a current review of literature and the authors' own experience with liver resection due to gastric cancer metastases into this organ. During 34 months, 488 patients with liver metastases were treated in the Department of General, Transplant and Liver Surgery, of the Medical University of Warsaw, in whom 426 surgical procedures were performed (87.3%). The types of surgical procedures are as follows: minor liver resections in 204 patients (47.9%), hemihepatectomies in 102 patients (23.9%), thermoablations in 86 patients (20.2%) and laparotomies in 34 patients (8.0%). Among patients treated for liver metastases there were 4 patients with metastases from gastric cancer (0.8%), which constituted 1% of patients operated on, but 6.8% of patients with liver metastases from organs other than colorectal cancer. The postoperative course and direct results in all patients operated because of gastric cancer metastases into the liver were very good. Conclusions . In some patients (single metachronous metastasis, no extrahepatic lesions, no peritoneal lesions, with subsequent chemotherapy) liver resection due to metastases from gastric cancer provides a chance for a longer survival.

show abstract

Section: Introductionmentioning

confidence: 99%

Metastases of gastric cancer into the liver – the authors’ own experience and literature review

Krawczyk¹,

Skalski²,

Grąt³

et al. 2019

Nowotwory. Journal of Oncology

View full text Add to dashboard Cite

show abstract

Preoperative Prognostic Factors After Liver Resection for Non‐Colorectal, Non‐Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population

et al. 2017

View full text Add to dashboard Cite

Liver resection for NCNN liver metastases is a safe and viable treatment option in carefully selected patients. Significant preoperative prognostic factors include adenocarcinoma primary tumours, disease-free interval and number of nodules. The total Adam score was a good predictor of overall survival and can be used to risk stratify patients undergoing hepatic resection for NCNN liver metastases.

show abstract

Hepatic resection of non-colorectal non-endocrine liver metastases

Cited by 2 publications

References 0 publications

Metastases of gastric cancer into the liver – the authors’ own experience and literature review

Metastases of gastric cancer into the liver – the authors’ own experience and literature review

Preoperative Prognostic Factors After Liver Resection for Non‐Colorectal, Non‐Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population

Contact Info

Product

Resources

About